FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to a method for assessing the number of donor erythrocytes circulating in the blood of a recipient by studying the patient's Rh phenotype, namely antigens D, C, c, E, e, and K, after allogeneic transplantation of hematopoietic stem cells (allo-HSCT).
EFFECT: method provides early and accurate diagnosis of the dynamics of the appearance of donor hematopoiesis after allo-HSCT, as well as the recipient's own hematopoiesis in case of relapse of the disease.
1 cl, 7 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING POSTTRANSPLANTATION CHIMERISM IN COURSE OF STUDY OF ABO SYSTEM ERYTHROCYTE ANTIGENS | 2020 |
|
RU2758064C1 |
| METHOD FOR DETERMINING HEMATOPOIETIC CHIMERISM IN THE STUDY OF SINGLE NUCLEOTIDE POLYMORPHISMS OF GENES MTHER: 677, MTHER: 1298, MTR: 2756, MTRR: 66 | 2017 |
|
RU2667127C1 |
| METHOD FOR DETERMINING POSTTRANSPLANTATION CHIMERISM IN ANALYSIS OF POINT MUTATIONS OF BASE SUBSTITUTION IN GENES F2, F5, F7, F13, FGB, ITGA2, ITGB3, PAI-1 | 2017 |
|
RU2667006C1 |
| METHOD OF TREATING RECURRENT ACUTE MYELOID LEUKAEMIA FOLLOWING TRANSPLANTATION OF ALLOGENIC HAEMOPOIETIC STEM CELLS | 2013 |
|
RU2538799C1 |
| METHOD OF SYNOVIAL FLUID GROUP SPECIFICITY DETERMINATION | 2008 |
|
RU2350958C1 |
| METHOD OF PREPARING UNIVERSAL HEMOTRANSFUSION MEDIUM | 1999 |
|
RU2151604C1 |
| ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN TRANSPLANTATION AND DISEASE TREATMENT | 2009 |
|
RU2506311C2 |
| METHOD OF COMPLETING CRYOPRESERVED ERYTHROCYTE RESERVE BASED ON IMMUNOHEMATOLOGICAL CRITERIA | 2019 |
|
RU2708631C1 |
| METHOD OF ASSESSING MINIMAL RESIDUAL DISEASE (MRD) BY MULTICOLOR FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN THE POST-INDUCTION PHASE OF TREATMENT | 2022 |
|
RU2802131C1 |
| COMBINATION THERAPY FOR STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B-CELL DEPLETION | 2012 |
|
RU2648354C2 |
